Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
A strange question from my formulator friends A strange question from my formulator friends A strange question from my formulator friends	jag009	2013-08-03 23:23	2	2013-08-05 13:38	2,773
Pulling a CMS during DCP	ElMaestro	2013-07-31 15:27	0		1,622
Reference listed drugs (RLD) for submission to EMEA Reference listed drugs (RLD) for submission to EMEA No RLDs in Europe	sparsh	2013-07-31 13:01	2	2013-07-31 11:36	8,443
Assigning Co/Sub investigator for the study protocol Assigning Co/Sub investigator for the study protocol	vivekanand	2013-07-18 12:52	1	2013-07-21 22:21	2,719
Dosing activity in BA/BE studies Dosing activity in BA/BE studies Dosing activity in BA/BE studies Dosing activity in BA/BE studies Dosing activity in BA/BE studies	manoj	2013-07-16 13:36	4	2013-07-18 11:05	3,260
Change in study design and required approval Change in study design and required approval Change in study design and required approval Change in study design and required approval Three-way with two sequences? Three-way with two sequences? Period effects!	docksr	2013-07-10 11:13	6	2013-07-16 11:53	4,883
Retention samples Retention samples Retention samples Retention samples	anky1212	2013-07-12 06:49	3	2013-07-15 14:14	4,056
Retention Period for the archived documents Retention Period for the archived documents	Irukulla Shravan Kumar	2013-07-08 06:10	1	2013-07-08 20:34	2,319
Submission in USA & Canada Canadian reference Canadian reference Non-Canadian reference Non-Canadian reference Non-Canadian reference Canadian reference North American POVs / posting statistics Submission in USA & Canada Submission in USA & Canada Submission in USA & Canada Submission in USA & Canada	Compliance	2013-07-05 13:29	11	2013-07-08 13:12	8,323
submission to two countries submission to two countries submission to two countries	sarada06884	2013-07-06 11:10	2	2013-07-07 06:03	3,011
Destruction of IPs Destruction of IPs Destruction of IPs Destruction of IPs Destruction of IPs Protect our and your environment! Destruction of IPs Destruction of IPs	Irukulla Shravan Kumar	2013-07-02 09:13	7	2013-07-04 06:24	4,359
Requirement for QPPV in EU clinical trials	Tina	2013-07-02 14:07	0		1,563
Selection of Reference for Canadian submission Selection of Reference for Canadian submission	Compliance	2013-06-24 13:30	1	2013-07-01 09:39	3,707
Sampling Time Point Deviation in EMEA study Sampling Time Point Deviation in EMA study	sandipmumbai	2013-06-28 10:59	1	2013-06-28 09:27	2,856
OGD revision OGD revision	suchit_bhavsar	2013-06-25 11:16	1	2013-06-28 06:54	2,554